References
- Adamczyk A, Stolarz-Skrzypek K, Wesolowska A, et al. Vitamin D and vitamin D receptor activators in treatment of hypertension and cardiovascular disease. Cardiovasc Hematol Disord Drug Targets 2014 . (Epub ahead of print)
- Belorusova AY, Eberhardt J, Potier N, et al. Structural insights into the molecular mechanism of Vitamin D Receptor activation by lithocholic acid involving a new mode of ligand recognition. J Med Chem 2014;57:4710–9
- Santoro D, Gagliostro G, Alibrandi A, et al. Vitamin D receptor gene polymorphism and left ventricular hypertrophy in chronic kidney disease. Nutrients 2014;6:1029–37
- Qin WH, Wang HX, Qiu JL, et al. A meta-analysis of association of vitamin D receptor BsmI gene polymorphism with the risk of type 1 diabetes mellitus. J Recept Signal Transduct Res 2014 . (Epub ahead of print)
- Ou C, Zhao HL, Zhu B, et al. Association of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: a meta-analysis. J Recept Signal Transduct Res 2014. (Epub ahead of print)
- Colombini A, Brayda-Bruno M, Lombardi G, et al. FokI polymorphism in the vitamin D receptor gene (VDR) and its association with lumbar spine pathologies in the Italian population: a case-control study. PLoS One 2014;9:e97027
- Zhou TB, Jiang ZP, Lin ZJ, et al. Association of vitamin D receptor gene polymorphism with the risk of systemic lupus erythematosus. J Recept Signal Transduct Res 2014. (Epub ahead of print)
- Zhu B, Zhao HL, Ou C, et al. Association of vitamin D receptor BsmI gene polymorphism with the risk of type 2 diabetes mellitus. J Recept Signal Transduct Res 2014. (Epub ahead of print)
- Kan WC, Chou YH, Chiu SJ, et al. Study of the association between ITPKC genetic polymorphisms and calcium nephrolithiasis. Biomed Res Int 2014;2014:397826
- Aggarwal KP, Narula S, Kakkar M, et al. Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. Biomed Res Int 2013;2013:292953
- Zhou TB, Yin SS. Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schonlein purpura in children. Ren Fail 2013;35:425–9
- Zhou TB, Yin SS, Jiang ZP. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J Recept Signal Transduct Res 2013;33:325–31
- Liu G, Zhou TB, Jiang Z, et al. Relationship between PPARgamma Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis. J Recept Signal Transduct Res 2014;34:131–6
- Zhou TB, Guo XF, Yin SS. Association of peroxisome proliferator-activated receptor gamma Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population. J Recept Signal Transduct Res 2014;34:180–4
- Ruggiero M, Pacini S, Amato M, et al. Association between vitamin D receptor gene polymorphism and nephrolithiasis.Miner Electrolyte Metab 1999;25:185–90
- Ferreira LG, Pereira AC, Heilberg IP. Vitamin D receptor and calcium-sensing receptor gene polymorphisms in hypercalciuric stone-forming patients. Nephron Clin Pract 2010;114:c135–44
- Vezzoli G, Soldati L, Proverbio MC, et al. Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones. J Nephrol 2002;15:158–64
- Mittal RD, Mishra DK, Srivastava P, et al. Polymorphisms in the vitamin D receptor and the androgen receptor gene associated with the risk of urolithiasis. Indian J Clin Biochem 2010;25:119–26